drugset / Trial / NCT00654524
Randomized Study of Gonadotropin-releasing-hormone Agonist (GnRH-a) or Expectant Management for Endometriosis
RandomizedParallel-groupOpen-labelSupportive care
Summary
The purpose of this study is to identify the recurrent rate and pregnancy rate of advanced endometriosis after laparoscopic surgery plus GnRHa goserelin acetate treatment.
Timeline
- Start
- 2008-03
- Primary completion
- 2009-12
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Goserelin | Other / unclassified | 3.6 mg | — |
| Background | Caltrate With Vitamin D | Unknown | 600 mg | Oral |
| Background | Tibolone | Other / unclassified | 1.25 mg | Oral |
| Background | Tibolone | Other / unclassified | 2.5 mg | Oral |